Cargando…

Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017

Introduction: Chloral hydrate (CH) has long been utilized as a pediatric procedural sedation agent. However, very little is published describing CH use in a pediatric intensive care unit (PICU) setting. The aim of this retrospective observational cohort study was to investigate and describe the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettinger, Nicholas A., Kiskaddon, Amy, McNeely, Lindsay, Craycraft, Justin, Rogers, Amber, Achuff, Barbara-Jo, Guffey, Danielle, Musick, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192606/
https://www.ncbi.nlm.nih.gov/pubmed/37214459
http://dx.doi.org/10.3389/fphar.2023.1111528
_version_ 1785043659415093248
author Ettinger, Nicholas A.
Kiskaddon, Amy
McNeely, Lindsay
Craycraft, Justin
Rogers, Amber
Achuff, Barbara-Jo
Guffey, Danielle
Musick, Matthew
author_facet Ettinger, Nicholas A.
Kiskaddon, Amy
McNeely, Lindsay
Craycraft, Justin
Rogers, Amber
Achuff, Barbara-Jo
Guffey, Danielle
Musick, Matthew
author_sort Ettinger, Nicholas A.
collection PubMed
description Introduction: Chloral hydrate (CH) has long been utilized as a pediatric procedural sedation agent. However, very little is published describing CH use in a pediatric intensive care unit (PICU) setting. The aim of this retrospective observational cohort study was to investigate and describe the use of CH in mechanically-ventilated, critically ill children at a large pediatric tertiary referral hospital. Methods: Data were extracted from the hospital electronic medical record and a locally maintained registry of all children admitted to the PICU between 2012 and 2017. Patients admitted to the cardiovascular ICU were not included in this review. The clinical and pharmacy data for 3806 consecutive PICU admissions of mechanically-ventilated, critically ill children were examined. Results: 283 admissions received CH during their first ICU stay. CH-exposed children were younger (16 months vs. 35 months, p < 0.001), the median total dose of CH (indexed to duration of ventilation) was 11 mg/kg/day, the median time to first CH dose was 3 days and more CH doses were administered at night (1112 vs. 958, p < 0.001). We constructed a propensity score to adjust for the differences in patients with and without CH exposure using logistic regression including variables of age, sex, diagnosis, and PRISM3 score. After adjustment, the median length of mechanical ventilation was 5 days longer in the CH-exposed group (95% Confidence Interval [CI] 4–6) compared to unexposed CH patients. Similarly, the median length of ICU duration was 9.4 days longer (95% CI 7.1–11.6) and median length of hospital admission duration was 13.2 days longer (95% CI 7.8–18.6) in CH-exposed patients compared to CH-non-exposed. After adjustment, CH-exposed patients had a 9% higher median exposure to HFOV (95% CI 3.9–14.6), but did not have higher median exposures to new tracheostomy (95% CI −0.4–2.2) or ECMO (95% CI −0.2–5.0). Discussion: As part of an extended sedation regimen in mechanically-ventilated and critically ill children, CH is associated with somewhat higher complexity of illness and longer ICU durations.
format Online
Article
Text
id pubmed-10192606
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101926062023-05-19 Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017 Ettinger, Nicholas A. Kiskaddon, Amy McNeely, Lindsay Craycraft, Justin Rogers, Amber Achuff, Barbara-Jo Guffey, Danielle Musick, Matthew Front Pharmacol Pharmacology Introduction: Chloral hydrate (CH) has long been utilized as a pediatric procedural sedation agent. However, very little is published describing CH use in a pediatric intensive care unit (PICU) setting. The aim of this retrospective observational cohort study was to investigate and describe the use of CH in mechanically-ventilated, critically ill children at a large pediatric tertiary referral hospital. Methods: Data were extracted from the hospital electronic medical record and a locally maintained registry of all children admitted to the PICU between 2012 and 2017. Patients admitted to the cardiovascular ICU were not included in this review. The clinical and pharmacy data for 3806 consecutive PICU admissions of mechanically-ventilated, critically ill children were examined. Results: 283 admissions received CH during their first ICU stay. CH-exposed children were younger (16 months vs. 35 months, p < 0.001), the median total dose of CH (indexed to duration of ventilation) was 11 mg/kg/day, the median time to first CH dose was 3 days and more CH doses were administered at night (1112 vs. 958, p < 0.001). We constructed a propensity score to adjust for the differences in patients with and without CH exposure using logistic regression including variables of age, sex, diagnosis, and PRISM3 score. After adjustment, the median length of mechanical ventilation was 5 days longer in the CH-exposed group (95% Confidence Interval [CI] 4–6) compared to unexposed CH patients. Similarly, the median length of ICU duration was 9.4 days longer (95% CI 7.1–11.6) and median length of hospital admission duration was 13.2 days longer (95% CI 7.8–18.6) in CH-exposed patients compared to CH-non-exposed. After adjustment, CH-exposed patients had a 9% higher median exposure to HFOV (95% CI 3.9–14.6), but did not have higher median exposures to new tracheostomy (95% CI −0.4–2.2) or ECMO (95% CI −0.2–5.0). Discussion: As part of an extended sedation regimen in mechanically-ventilated and critically ill children, CH is associated with somewhat higher complexity of illness and longer ICU durations. Frontiers Media S.A. 2023-05-04 /pmc/articles/PMC10192606/ /pubmed/37214459 http://dx.doi.org/10.3389/fphar.2023.1111528 Text en Copyright © 2023 Ettinger, Kiskaddon, McNeely, Craycraft, Rogers, Achuff, Guffey and Musick. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ettinger, Nicholas A.
Kiskaddon, Amy
McNeely, Lindsay
Craycraft, Justin
Rogers, Amber
Achuff, Barbara-Jo
Guffey, Danielle
Musick, Matthew
Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title_full Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title_fullStr Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title_full_unstemmed Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title_short Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012–2017
title_sort retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (picu) patients 2012–2017
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192606/
https://www.ncbi.nlm.nih.gov/pubmed/37214459
http://dx.doi.org/10.3389/fphar.2023.1111528
work_keys_str_mv AT ettingernicholasa retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT kiskaddonamy retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT mcneelylindsay retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT craycraftjustin retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT rogersamber retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT achuffbarbarajo retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT guffeydanielle retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017
AT musickmatthew retrospectiveobservationalstudyofchloralhydrateuseinmechanicallyventilatedpediatricintensivecareunitpicupatients20122017